Sign in

Analyzing Key Drivers and Insights Shaping the Postpartum Depression Market Outlook

Jayanthi TBRC
Analyzing Key Drivers and Insights Shaping the Postpartum Depression Market Outlook

Overview and Scope

Postpartum depression (PPD) refers to a condition, which is a type of mood disorder that affects some women after giving birth and can remain undiagnosed for long periods of time. It is characterized by feelings of sadness, hopelessness and a lack of interest or pleasure in once-enjoyable activities.

Sizing and Forecast

The postpartum depression market size has grown exponentially in recent years. It will grow from $9.17 billion in 2023 to $12.15 billion in 2024 at a compound annual growth rate (CAGR) of 32.5%. The growth in the historic period can be attributed to maternal mental health awareness, research advancements, public health initiatives, increased screenings.

The postpartum depression market size is expected to see exponential growth in the next few years. It will grow to $36.96 billion in 2028 at a compound annual growth rate (CAGR) of 32.1%. The growth in the forecast period can be attributed to telehealth services, pharmacological advancements, maternal mental health legislation, mental health workforce expansion. Major trends in the forecast period include integrated care models, peer support programs, perinatal mental health apps, mental health screening tools.

To access more details regarding this report, visit the link:


Segmentation & Regional Insights

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues; Postpartum Anxiety; Postpartum Obsessive Compulsive Disorder; Postpartum Panic Disorder; Postpartum Post-Traumatic Stress Disorder; Postpartum Psychosis; Other Types

2) By Treatment: Psychotherapy; Medication; Supplements; Other Treatments

3) By Route of Administration: Oral; Parenteral; Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users

North America was the largest region in the postpartum depression market in 2023. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:


Major Driver Impacting Market Growth

An increase in postpartum depression cases is expected to propel the growth of the postpartum depression market going forward. Postpartum depression is an exaggerated worry that develops after giving birth. There may be physical symptoms in addition to it. Postnatal depression and postpartum anxiety frequently coexist and in the first year after giving birth, symptoms might start at any time. Postpartum depression is frequently treated with psychotherapy, commonly known as talk therapy or mental health counseling, medication, or a combination of the two, which results in the growth of the market. For Instance, in May 2022, according to UVA Medical Center, a US-based academic medical center with hospitals and specialty clinics, in the US the rates of postpartum depression symptoms steadily increased by 7.7% between December 2020 and March 2021. Further, there was an increase in postpartum depression symptoms in 36 of the 50 U.S. states and the District of Columbia in 2021. Therefore, an increase in postpartum depression cases will drive the postpartum depression market.

Key Industry Players

Major players in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

The postpartum depression market report table of contents includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis




27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:


Mental Health Apps Global Market Report 2024


Behavioral and Mental Health Software Global Market Report 2024


Residential Substance Abuse And Mental Health Facilities Global Market Report 2024

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Jayanthi TBRC
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more